ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Nurse Practitioner, Family

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,214Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 79

$534K Total Retail Price of All Prescriptions

Rank: 4 out of 79

619 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
40% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nevada
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 619 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

23% of this provider’s 619 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

1% of this provider’s 8,756 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

16% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $77 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 8.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nevada
HYDROCODONE-ACETAMINOPHEN 715 493 S3 1 2
OMEPRAZOLE 543 413 2 5
LISINOPRIL 505 438 3 3
LEVOTHYROXINE SODIUM 446 356 4 4
SIMVASTATIN 440 332 5 1
AMLODIPINE BESYLATE 351 307 6 6
PRAVASTATIN SODIUM 310 269 7 22
METFORMIN HCL 276 224 8 7
FUROSEMIDE 272 243 9 9
LOSARTAN POTASSIUM 265 244 10 11
LOVASTATIN 261 248 11 14
PAROXETINE HCL 215 138 12 59
CARVEDILOL 161 152 13 36
METOPROLOL TARTRATE 156 140 14 18
ALENDRONATE SODIUM 153 136 15 24
POTASSIUM CHLORIDE 141 122 16 29
GLIMEPIRIDE 137 112 17 58
GABAPENTIN 132 87 18 15
METOPROLOL SUCCINATE 131 122 19 23
RANITIDINE HCL 130 68 20 46
HYDROCHLOROTHIAZIDE 115 72 21 13
TIZANIDINE HCL 109 74 22 45
ZOLPIDEM TARTRATE 108 63 23 10
CITALOPRAM HBR 107 93 24 30
ALLOPURINOL 106 105 25 39
MORPHINE SULFATE ER 106 31 S2 25 25
SPIRIVA 99 90 27 16
NEXIUM 97 68 28 98
ATORVASTATIN CALCIUM 94 79 29 47
CLOPIDOGREL 93 79 30 56
METHADONE HCL 92 48 S2 31 40
WARFARIN SODIUM 90 71 32 8
OXYCODONE HCL-ACETAMINOPHEN 88 32 S2 33 31
FLUTICASONE PROPIONATE 86 55 34 17
LOSARTAN-HYDROCHLOROTHIAZIDE 83 72 35 60
NAPROXEN 82 64 36 85
FLUOXETINE HCL 81 68 37 54
CIPROFLOXACIN HCL 79 73 38 51
FINASTERIDE 77 77 39 86
OXYCODONE HCL 74 28 S2 40 12
TAMSULOSIN HCL 74 65 40 44
ROPINIROLE HCL 69 50 42 115
DONEPEZIL HCL 67 66 43 68
SERTRALINE HCL 67 58 43 38
ATENOLOL 64 62 45 28
BENAZEPRIL HCL 63 63 46 83
DILTIAZEM 24HR CD 62 62 47 123
LISINOPRIL-HYDROCHLOROTHIAZIDE 61 56 48 41
PLAVIX 61 50 48 66
TRAZODONE HCL 60 32 50 43
AMOXICILLIN 60 48 50 92
ISOSORBIDE MONONITRATE ER 59 59 52 69
PREDNISONE 55 43 53 20
AZITHROMYCIN 53 39 54 26
PROAIR HFA 52 33 55 42
ESTRADIOL 51 18 R 56 95
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 30, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.